Question 1

Does Renaissance Technologies own ENLV stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Renaissance Technologies holds 133,900 shares of ENLV (Enlivex Therapeutics), worth $73,632.

Question 2

How many shares of ENLV does Renaissance Technologies own?

Accepted Answer

As of its Q2 2026 13F, Renaissance Technologies holds 133,900 shares of ENLV (Enlivex Therapeutics).

Question 3

What is Renaissance Technologies' ENLV position worth?

Accepted Answer

As of its Q2 2026 13F, Renaissance Technologies' ENLV position is worth $73,632.

Question 4

Is Renaissance Technologies buying or selling ENLV?

Accepted Answer

In Q2 2026, Renaissance Technologies increased its ENLV position by 5,708 shares (+4.5%).

Question 5

When did Renaissance Technologies first buy ENLV?

Accepted Answer

Renaissance Technologies already held ENLV in its Q3 2019 13F, the earliest on record, and has listed it in 28 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	133,900	+4.5%	$73,632	0.0%	$131.98	22
2026-Q1	Decreased	128,192	-59.1%	$119,231	0.0%	$223.22	0
2025-Q4	Increased	313,628	+99.4%	$220,543	0.0%	$168.77	37
2025-Q3	Decreased	157,292	-6.6%	$163,584	0.0%	$249.60	0
2025-Q2	Decreased	168,392	-7.1%	$188,599	0.0%	$268.80	0
2025-Q1	Increased	181,289	+14.0%	$175,887	0.0%	$232.85	26
2024-Q4	Increased	158,992	+112.6%	$186,021	0.0%	$280.80	37
2024-Q3	Increased	74,789	+4.3%	$125,646	0.0%	$403.20	23

ENLVShowing 8 of 28 quarters

ENLV
Showing 8 of 28 quarters